CRL
Charles River Laboratories International, Inc. · Healthcare
Chair, President and CEO James C Foster sold $5.0M of Charles River Laboratories International, Inc.
Sold$5,000,017
$250.00Price
20,000Shares
−7%Stake
What CRL did after the filing
- The stock from Fri, Feb 17 close, $249.76
- −19.8%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Apr 3 close.
Traded Wed, Feb 15. Filed Fri, Feb 17, 11:02 AM ET, during the session. Returns use the Feb 17 close and the Apr 3 close. Not investment advice.